Sonio
Explore this company’s associated devices, FDA decisions and regulatory history.

Sonio
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Sonio. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 16, 2026 to Jun 4, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code IYN appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 147 Rue D'Aboukir, Paris, 750002, FR. Recorded on K261519, decision dated Jun 4, 2026.
Device categories in this collection
Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer; System, Imaging, Pulsed Doppler, Ultrasonic.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Sonio Suspect
K261519 · 510(k) clearanceSonio Detect (v3)
K252433 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.